Humacyte (HUMA) Invested Capital (2020 - 2026)
Humacyte (HUMA) posted quarterly Invested Capital of $40.1 million for Q1 2026, up 2275.5% year-over-year from $1.7 million in Q1 2025, and little changed quarter-over-quarter from $40.0 million in Q4 2025.
Humacyte (HUMA) Invested Capital (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Invested Capital for 7 consecutive years, with $40.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital rose 2275.5% year-over-year to $40.1 million; the TTM figure through Mar 2026 stood at $112.1 million (up 516.06% YoY), while the FY2025 annual figure was $40.0 million, up 142.42% from the prior year.
- Invested Capital steadied at $40.1 million in Q1 2026 per HUMA's latest filing, from $40.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $40.1 million in Q1 2026 and bottomed at $1.7 million in Q1 2025.
- Historically, Invested Capital has averaged $18.7 million across 5 years, with a median of $17.7 million in 2023.
- Annual changes were most pronounced in 2024 — Invested Capital declined 12.7% — and 2026, when it soared 2275.5%.
- Humacyte's Invested Capital stood at $21.1 million in 2022, then declined by 10.43% to $18.9 million in 2023, then slipped by 12.7% to $16.5 million in 2024, then jumped by 142.42% to $40.0 million in 2025, then climbed by 0.36% to $40.1 million in 2026.
- Business Quant data shows HUMA's Invested Capital at $40.1 million in Q1 2026, $40.0 million in Q4 2025, and $29.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Humacyte | 150.77 Mn | 150.77 Mn | -825,000.00 | 40.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.30 Mn |
| Mar 31, 2026 | 40.15 Mn |
| Dec 31, 2025 | 40.00 Mn |
| Sep 30, 2025 | 29.80 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 16.50 Mn |
| Dec 31, 2023 | 18.90 Mn |
| Mar 31, 2023 | 12.86 Mn |
| Dec 31, 2022 | 21.10 Mn |
| Sep 30, 2022 | 4.29 Mn |
| Dec 31, 2021 | 23.10 Mn |
| Sep 30, 2021 | 3.89 Mn |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 24.80 Mn |
| Sep 30, 2020 | 4,334.00 |